Premium
F4‐01‐03: A BIOMARKER‐BASED NUTRITIONAL RISK INDEX EXPLAINS THE HETEROGENEITY IN RATES OF COGNITIVE DECLINE IN THE MULTI‐DOMAIN ALZHEIMER PREVENTION TRIAL (MAPT)
Author(s) -
Bowman Gene L.,
Dodge Hiroko,
Guyonnet Sophie,
Zhou Nina,
Donohue Juliana,
Bichel Aline,
Schmitt Jeroen,
Hooper Claudie,
Barfai Tamas,
Andrieu Sandrine,
Vellas Bruno
Publication year - 2018
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2018.06.2866
Subject(s) - cognitive decline , medicine , population , biomarker , homocysteine , cognition , randomized controlled trial , gerontology , demography , disease , dementia , biology , psychiatry , environmental health , biochemistry , sociology